JNJ vs. META: Johnson & Johnson vs. Meta Platforms Stock Comparison

November 11, 2026

How do Johnson & Johnson (JNJ) and Meta Platforms (META) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

Johnson & Johnson (JNJ) is classified in the Health Care sector (Pharmaceuticals, Biotechnology & Life Sciences), whereas Meta Platforms (META) belongs to Communication Services (Media & Entertainment) — their GICS classifications point to very different parts of the market.

Company profile comparison for Johnson & Johnson (JNJ) and Meta Platforms (META)
Profile Item	JNJ	META
Name	Johnson & Johnson	Meta Platforms Inc. Class A Common Stock
Country/Region	United States	United States
GICS Sector	Health Care	Communication Services
GICS Industry Group	Pharmaceuticals, Biotechnology & Life Sciences	Media & Entertainment
GICS Industry	Pharmaceuticals	Interactive Media & Services
GICS Sub-Industry	Pharmaceuticals	Interactive Media & Services
Market Capitalization	664.95 billion USD	1,560.05 billion USD
Currency	USD	USD
Exchange	NYSE	Nasdaq
Listing Date	January 2, 1962	May 18, 2012
Security Type	Common Stock	Common Stock

Price Performance

Cumulative Growth

JNJ

META

GSPC

Johnson & Johnson (JNJ) vs. Meta Platforms (META), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…

Trailing total returns for Johnson & Johnson (JNJ) and Meta Platforms (META). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…

Calendar-year total returns for Johnson & Johnson (JNJ) and Meta Platforms (META). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for Johnson & Johnson (JNJ) and Meta Platforms (META)
Metric	JNJ	META
Total Return (1Y)	53.82%	3.46%
Total Return (3Y, Annualized)	27.51%	26.39%
Total Return (5Y, Annualized)	14.71%	14.05%

Risk Profile

Drawdown History

JNJ

META

GSPC

Johnson & Johnson (JNJ) vs. Meta Platforms (META), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…

Distribution of monthly total returns for Johnson & Johnson (JNJ) and Meta Platforms (META). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Risk profile metrics for Johnson & Johnson (JNJ) and Meta Platforms (META)
Metric	JNJ	META
Volatility (1Y, Annualized)	21.23%	41.68%
Beta (5Y)	0.21	1.26
Max Drawdown (5Y)	-18.41%	-74.42%
Avg. Volume (3M)	6.93M	20.91M

Risk-Adjusted Performance

Risk-Return Positioning

JNJ and META are plotted by 1-year volatility (risk) and 1-year return. Each dashed Capital Allocation Line uses that stock's own industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for Johnson & Johnson (JNJ) and Meta Platforms (META)
Metric	JNJ	META
Sharpe Ratio (1Y)	2.33	-0.02
Sortino Ratio (1Y)	3.66	-0.03

Profitability

ROE (TTM)

Both Johnson & Johnson (JNJ) at 20.02% and Meta Platforms (META) at 32.26% sit in the top peer quartile for ROE, suggesting each generates more profit from shareholders’ equity than typical industry peers.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

20.02%

Max: 109.18%
JNJ: 20.02%
Q3: 6.23%
Median: -26.66%
Q1: -64.05%
Min: -167.77%

META

Media & Entertainment industry group

32.26%

Max: 49.92%
META: 32.26%
Q3: 17.95%
Median: 7.20%
Q1: -4.53%
Min: -26.31%

Johnson & Johnson (JNJ) vs. Meta Platforms (META): A comparison of their ROE against their respective Pharmaceuticals, Biotechnology & Life Sciences and Media & Entertainment industry group benchmarks.

Net Margin (TTM)

For every dollar of sales, both Johnson & Johnson (JNJ) at 16.20% and Meta Platforms (META) at 31.15% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

16.20%

Max: 18.05%
JNJ: 16.20%
Q3: 4.78%
Median: 0.00%
Q1: -4.14%
Min: -17.05%

META

Media & Entertainment industry group

31.15%

Max: 32.91%
META: 31.15%
Q3: 11.75%
Median: 5.04%
Q1: -4.17%
Min: -25.14%

Johnson & Johnson (JNJ) vs. Meta Platforms (META): A comparison of their net margin against their respective Pharmaceuticals, Biotechnology & Life Sciences and Media & Entertainment industry group benchmarks.

Operating Margin (TTM)

Both Johnson & Johnson (JNJ) at 25.74% and Meta Platforms (META) at 35.41% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

25.74%

Max: 83.12%
JNJ: 25.74%
Q3: 14.77%
Median: 0.00%
Q1: -78.82%
Min: -207.40%

META

Media & Entertainment industry group

35.41%

Max: 40.16%
META: 35.41%
Q3: 18.72%
Median: 8.63%
Q1: 1.90%
Min: -22.08%

Johnson & Johnson (JNJ) vs. Meta Platforms (META): A comparison of their operating margin against their respective Pharmaceuticals, Biotechnology & Life Sciences and Media & Entertainment industry group benchmarks.

Profitability Metrics

Profitability metrics for Johnson & Johnson (JNJ) and Meta Platforms (META)
Metric	JNJ	META
ROE (TTM)	20.02%	32.26%
ROA (TTM)	8.46%	14.58%
Net Margin (TTM)	16.20%	31.15%
Operating Margin (TTM)	25.74%	35.41%
Gross Margin (TTM)	67.78%	81.03%

Growth

Revenue Growth

Meta Platforms (META) at 22.17% sits in the top revenue growth quartile, while Johnson & Johnson (JNJ) at 6.05% is closer to the peer norm — faster top-line expansion for META.

Johnson & Johnson (JNJ) vs. Meta Platforms (META): A comparison of their Revenue Growth across different time periods.

EPS Growth

Johnson & Johnson (JNJ) at 90.50% sits in the top EPS growth quartile, while Meta Platforms (META) at -1.55% is closer to the peer norm — faster per-share earnings growth for JNJ.

Johnson & Johnson (JNJ) vs. Meta Platforms (META): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for Johnson & Johnson (JNJ) and Meta Platforms (META)
Metric	JNJ	META
Revenue Growth (YoY)	6.05%	22.17%
Revenue Growth (3Y CAGR)	5.60%	19.89%
EPS Growth (YoY)	90.50%	-1.55%
EPS Growth (3Y CAGR)	17.90%	39.84%

Financial Strength

Current Ratio (MRQ)

Meta Platforms (META) at 1.90 keeps current ratio within its industry’s typical mid-range, while Johnson & Johnson (JNJ) at 1.02 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for JNJ.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.02

Max: 25.13
Q3: 12.13
Median: 5.52
Q1: 2.47
JNJ: 1.02
Min: 0.10

META

Media & Entertainment industry group

1.90

Max: 4.69
Q3: 2.53
META: 1.90
Median: 1.52
Q1: 0.95
Min: 0.28

Johnson & Johnson (JNJ) vs. Meta Platforms (META): A comparison of their current ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Media & Entertainment industry group benchmarks.

Debt / Equity (MRQ)

Both Johnson & Johnson (JNJ) at 0.55 and Meta Platforms (META) at 0.42 fund their balance sheets with roughly industry-typical debt-to-equity mixes.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.55

Max: 1.42
Q3: 0.65
JNJ: 0.55
Median: 0.15
Q1: 0.02
Min: 0.00

META

Media & Entertainment industry group

0.42

Max: 3.65
Q3: 1.69
Median: 0.46
META: 0.42
Q1: 0.17
Min: 0.00

Johnson & Johnson (JNJ) vs. Meta Platforms (META): A comparison of their debt-to-equity ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Media & Entertainment industry group benchmarks.

Financial Strength Metrics

Financial strength metrics for Johnson & Johnson (JNJ) and Meta Platforms (META)
Metric	JNJ	META
Current Ratio (MRQ)	1.02	1.90
Debt / Equity (MRQ)	0.55	0.42
Net Debt / EBITDA	0.79	0.28

Dividends

Dividend Yield (TTM)

Meta Platforms (META) at 0.35% pays an industry-typical yield; Johnson & Johnson (JNJ) at 1.94% is above its entire peer range — the higher number, but one that calls for a look at payout sustainability before treating it as an advantage.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.94%

JNJ: 1.94%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

META

Media & Entertainment industry group

0.35%

Max: 1.33%
Q3: 0.65%
META: 0.35%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

Johnson & Johnson (JNJ) vs. Meta Platforms (META): A comparison of their dividend yield against their respective Pharmaceuticals, Biotechnology & Life Sciences and Media & Entertainment industry group benchmarks.

Dividend Payout Ratio (TTM)

Meta Platforms (META) at 7.16% keeps its payout in the industry’s typical band, while Johnson & Johnson (JNJ) at 80.12% pays out more than any of its peers — the most stretched cover in its group.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

80.12%

JNJ: 80.12%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

META

Media & Entertainment industry group

7.16%

Max: 71.43%
Q3: 28.98%
META: 7.16%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

Johnson & Johnson (JNJ) vs. Meta Platforms (META): A comparison of their payout ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Media & Entertainment industry group benchmarks.

Dividend Metrics

Dividend metrics for Johnson & Johnson (JNJ) and Meta Platforms (META)
Metric	JNJ	META
Dividend Yield (TTM)	1.94%	0.35%
Dividend Payout Ratio (TTM)	80.12%	7.16%

Valuation

P/E Ratio (TTM)

Both Johnson & Johnson (JNJ) at 41.92 and Meta Platforms (META) at 20.82 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

41.92

Max: 85.34
Q3: 43.46
JNJ: 41.92
Median: 26.69
Q1: 13.30
Min: 0.07

META

Media & Entertainment industry group

20.82

Max: 51.21
Q3: 28.90
META: 20.82
Median: 17.98
Q1: 11.53
Min: 1.64

Johnson & Johnson (JNJ) vs. Meta Platforms (META): A comparison of their P/E ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Media & Entertainment industry group benchmarks.

P/S Ratio (TTM)

Johnson & Johnson (JNJ) at 6.69 is priced about in line with its industry on P/S ratio, while Meta Platforms (META) at 6.46 sits in the pricier quartile — META costs more per dollar of sales.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

6.69

Max: 58.18
Q3: 25.77
Median: 7.30
JNJ: 6.69
Q1: 3.01
Min: 0.01

META

Media & Entertainment industry group

6.46

Max: 7.43
META: 6.46
Q3: 3.82
Median: 1.40
Q1: 0.70
Min: 0.00

Johnson & Johnson (JNJ) vs. Meta Platforms (META): A comparison of their P/S ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Media & Entertainment industry group benchmarks.

P/B Ratio (MRQ)

Both Johnson & Johnson (JNJ) at 8.16 and Meta Platforms (META) at 5.73 carry a premium to book value versus peers, sitting in the upper P/B ratio quartile of their industries.

JNJ

Pharmaceuticals, Biotechnology & Life Sciences industry group

8.16

Max: 13.53
JNJ: 8.16
Q3: 6.54
Median: 3.25
Q1: 1.69
Min: -5.59

META

Media & Entertainment industry group

5.73

Max: 11.45
META: 5.73
Q3: 5.30
Median: 1.84
Q1: 0.77
Min: -2.61

Johnson & Johnson (JNJ) vs. Meta Platforms (META): A comparison of their P/B ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Media & Entertainment industry group benchmarks.

Valuation Metrics

Valuation metrics for Johnson & Johnson (JNJ) and Meta Platforms (META)
Metric	JNJ	META
P/E Ratio (TTM)	41.92	20.82
P/S Ratio (TTM)	6.69	6.46
P/B Ratio (MRQ)	8.16	5.73
Free Cash Flow Yield (TTM)	2.78%	1.08%